K

V

Viking Global Investors

Crunchbase
Crunchbase

Deals on record

5

Common Fundraising Type

Series B

Metsera logo
Metsera

Biopharmaceutical • Clinical-stage

Venrock logo
Wellington Management logo
T. Rowe Price logo
SymBiosis logo

Metsera is a clinical-stage biopharmaceutical company developing next-generation treatments for obesity and metabolic diseases using their innovative platforms and Nutrient-Stimulated Hormone analog peptides.

Series B
$215M
11/13/2024
Article
Triveni Bio logo
Triveni Bio

Biotech • Antibody treatments

Goldman Sachs Alternatives logo
Viking Global Investors logo
OrbiMed logo
Invus logo

Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.

Series B
$115M
10/02/2024
Article
Lightmatter logo
Lightmatter

Photonic Chip Technology • AI

Viking Global Investors logo
GV logo

Lightmatter is a company that develops photonic chip technology to enhance AI and high-performance computing with a focus on reducing power consumption and increasing performance.

Series C
$155M
12/19/2023
Article
DermBiont logo
DermBiont

Biotechnology • Dermatology

Double Point Ventures logo
Viking Global Investors logo
Olive Tree Capital logo
Civilization Ventures logo

DermBiont is a clinical-stage biotechnology company that develops targeted topical therapeutics for dermatological indications, with a focus on treating seborrheic keratoses and melasma.

Series B
$35.2M
10/24/2023
Article
AlphaSense logo
AlphaSense

AI-based Market Intelligence • Financial Insights

Viking Global Investors logo
Goldman Sachs logo
CapitalG logo
BAM Elevate logo

AlphaSense is an AI-based market intelligence firm that provides structured financial insights to enterprise customers by combining data crawling and insights extraction from a wide range of sources.

Series E
$150M
09/28/2023
Article